AI-driven drug repurposing presents opportunities through cost-effective drug development, personalized medicine, and ...

The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract Development and Manufacturing Organisations (CDMOs).

Dan Sutherlin shares his insight on what the drug development industry will look like in the next 20 years How a 1,000-piece jigsaw puzzle creates an accurate analogy for drug development Technology ...

EvoRank offers a new and tangible example of how AI may help bring disruptive change to biomedical research and biotechnology more broadly. Using the MutRank framework trained with EvoRank, Danny Diaz ...

The U.S. Food and Drug Administration (FDA) announced a landmark decision on April 10, 2025, phasing out mandatory animal testing for drugs such as monoclonal antibodies. This revolutionary decision ...

May 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

They identified three promising molecules and then found that two blocked most FIKK kinases in a test tube. As blocking all FIKK kinases at once could be a promising treatment strategy to ease malaria ...